Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines

Clinical and Experimental Metastasis

Volumn 15, Issue 5, 1997, Pages 519-526

  Gilles, Christine ^a   Polette, Myriam ^b   Birembaut, Philippe ^b   Brünner, Nils ^c   Thompson, Erik W ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b HÔPITAL MAISON BLANCHE   (France)

^c FINSEN LABORATORY   (Denmark)

Author keywords

Breast cancer progression; C ets 1; EMT; Proteinases; Vimentin

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; TRANSCRIPTION FACTOR; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CELL SPECIFICITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE;

BREAST NEOPLASMS; CADHERINS; CARCINOMA; COLLAGENASES; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MESODERM; NEOPLASM INVASIVENESS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; VIMENTIN;

EID: 0030798703     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018427027270     Document Type: Article

References (56)

1. Stetler-Stevenson WG, Aznavoorian S and Liotta LA, 1993, Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol, 9, 541-73.
2. MacDougall JR and Matrisian L, 1995, Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metast Rev, 14, 351-62.
3. MacLeod K, Leprince D and Stehelin D, 1992, The ets gene family. Trends Biochem Sci, 17, 251-6.
4. Wasylyk B, Hahn SL and Giovane A, 1993, The Ets family of transcriptional factors. Eur J Biochem, 277, 7-18.
5. Leprince D, Gegonne A, Coll J, et al. 1983, A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature, 306, 395-7.
6. Nunn MF, Seeburg PH, Moscovici C and Duesberg PH, 1983, Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature, 306, 391-5.
7. Karim FD, Urness LD, Thummel CS, et al. 1990, The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Gene Dev, 4, 1451-3.
8. Quinones S, Sans J, Otari Y, Harris EDJ and Kurkinen M, 1989, Transcriptional regulation of human stromelysin. J Biol Chem, 264, 8339-44.
9. Gutman A and Wasylyk B, 1990, The collagenase gene promoter contains a TPA and oncogene-responsive unit emcompassing the PEA3 and AP-1 binding sites. EMBO J, 9, 2241-6.
10. Nerlov C, Rorth P, Blasi F and Johnsen M, 1991, Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell-type specific activity. Oncogene, 6, 1583-92.
11. Gaire M, Zenaida M, McDonnell S, McNeil L, Lovett DH and Matrisian LM, 1994, Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem, 269, 2032-40.
12. Wasylyk C, Gutman A, Nicholson R and Wasylyk B, 1991, The c-ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J, 10, 1127-34.
13. Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K, 1995, Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene, 10, 1461-63.
14. Crawford HC and Matrisian LM, 1996, Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme and Proteins, 49, 20-37.
15. Wernert N, Gilles F, Fafeur V, et al. 1994, Stromal expression of c-ets-1 transcription factor correlates with tumor invasion. Cancer Res, 54, 5683-8.
16. Vandenbunder B, Queva C, Desbiens X, Wernert N and Stehelin D, 1994-95, Expression of the transcription factor c-ets-1 correlates with the occurrence of invasive processes during normal and pathological development. Invasion & Metastasis, 14, 198-209.
17. Bolon I, Brambilla E, Vandenbunder B, Robert C, Lantuejoul S and Brambilla C, 1996, Changes in the expression of matrix proteases and of the transcription factor c-ets-1 during progression of precancerous bronchila lesions. Lab Invest, 75, 1-13.
18. Wernert N, Raes MB, Lasalle P, et al. 1992, c-ets-1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol, 140, 119-27.
19. Bolon I, Gouyer V, Devouassoux M, et al. 1995, Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in human lung carcinomas. Am J Pathol, 147, 1298-309.
20. Polette M and Birembaut P, 1996, Matrix metalloproteinases in breast carcinoma. The Breast Journal, 2, 209-20.
21. Gilles C and Thompson EW, 1996, The epithelial to mesenchymal transition and metastatic progression in carcinoma. The Breast Journal, 2, 83-96.
22. Savagner P, Boyer B, Valles AM, Jouanneau J and Thiery JP, 1994, Modulations of the epithelial phonotype during embryogenesis and cancer progression. In: Dickson R and Lippman M, eds. Mammary Tumorigenesis and Malignant Progression. Kluwer Academic Publishers, Chapter 12, pp. 229-49.
23. Guarino M, 1995, Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol, 10, 171-84.
24. Hay ED, 1995, An overview of epithelio-mesenchymal transformation. Acta Anat, 154, 8-20.
25. Sommers CL, Thompson EW, Torri JA, Kemler EP, Gelmann EP and Byers SW, 1991, Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth and Differentiation, 2, 365-72.
26. Thompson EW, Paik S, Brünner N, et al. 1992, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol, 150, 534-44.
27. Azzam HS and Thompson EW, 1992, Collagen-induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res, 52, 4540-4.
28. Azzam H, Arrand GA, Lippman ME and Thompson EW, 1993, MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J Natl Cancer Inst, 85, 1758-64.
29. Bae SN, Arand G, Azzam H, et al. 1993, Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res and Treat, 24, 241-55.
30. Gilles C, Polette M, Piette J, Birembaut P and Foidart JM, 1994, Epithelial to mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer, 59, 661-6.
31. Sommers CL, Byers SW, Thompson EW, Torri J and Gelmann EP, 1994, Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat, 31, 325-35.
32. Gilles C, Polette M, Piette J, et al. 1996, High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer, 65, 209-13.
33. Gilles C, Polette M, Piette J, Thompson EW, Foidart JM and Birembaut P, 1996, Vimentin expression in cervical carcinomas: association with the invasive and the migratory phonotype of tumor cells. J Pathol, 180, 175-80.
34. Pulyaeva H, Bueno J, Polette M, et al. 1997, MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis, 15, 111-20.
35. Gilles C, Polette M, Seiki M, Birembaut P and Thompson EW, Collagen type I-induced MT1-MMP expression and MMP-2 activation: implication in the metastatic progression of breast carcinoma. Lab Invest, in press.
36. Thompson EW, Nakamura S, Shima TB, et al. 1991, Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Res, 51, 2670-76.
37. Schuh R, Vestweber D, Riede I, et al. 1986, Molecular cloning of the mouse cell adhesion molecule uvomorulin: cDNA contains a B1-related sequence. Proc Natl Acad Sci USA, 83, 1364-68.
38. Sommers C, Walker-Jones D, Heckford SE, et al. 1989, Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res, 49, 4258-63.
39. Rømer J, Pyke C, Lund LR, et al. 1994, Expression of uPA and its receptor by both neoplastic and stromal cells during xenografts invasion. Int J Cancer, 57, 553-60.
40. Goldberg GI, Wilhem SM, Kronberger A, Bauer EA, Grant GA and Eisen AZ, 1986, Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem, 261, 6600-5.
41. Wilhelm SM, Collier IE, Kronberger A, et al. 1987, Human skin fibroblast stromelysin: structure, glycolylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci USA, 84, 6725-9.
42. Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V and Brünner N, 1996, Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis, 14, 297-307.
43. Price JE, Polyzos A, Zhang RD and Daniels LM, 1990, Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res, 50, 717-21.
44. Brünner N, Thompson EW, Spang-Thomsen M, Rygaard J, Danø K and Zwiebel JA, 1992, LacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur J Cancer, 28, 1989-95.
45. Frandsen TL, Boysen BE, Jirus S, et al. 1992, Assays for the study of human cancer cell invasion and metastasis. Fibrinolysis, 6, 71-6.
46. Borchers AH, Powell MB, Fusenig NE and Bowden T, 1994, Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res, 213, 143-7.
47. Gilles F, Raes MB, Stehelin D, Vandenbunder B and Fafeur V, 1996, The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp Cell Res, 222, 370-8.
48. Calmels TPG, Mattot V, Wernert N, Vandenbunder B and Stehelin D, 1995, Invasive tumors induce c-ets-1 transcription factor expression in adjacent stroma. Biol Cell, 84, 53-61.
49. Chen JH, Vercamer C, Li Z, Paulin D, Vandenbunder B and Stehelin D, 1996, PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene, 13, 1667-75.
50. Brünner N, Pyke C, Holst Hansen C, Rømer J, Grøndhal-Hansen J and Danø K, 1994, Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of the proteolysis during cancer invasion and prognostic parameters in breast cancer. In: Dickson R and Lippman M, eds. Mammary Tumorigenesis and Malignant Progression. Kluwer Academic Publishers, Chapter 16, pp. 299-309.
51. Basset P, Bellocq JP, Wolf C, et al. 1990, A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699-704.
52. Polette M, Clavel C, Cockett M, Girod de Bentzmann S, Murphy G and Birembaut P, 1993, Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metast, 13, 31-7.
53. Okada A, Bellocq JP, Rouyer N, et al. 1995, Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA, 92, 730-4.
54. Kaya M, Yoshida K, Higasahino F, Mitaka T, Ishii S and Fujinaga K, 1996, A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene, 12, 221-7.
55. Wasylyk B, Wasylyk C, Flores P, Begue A, Leprince D and Stehelin D, 1990, The c-ets proto-oncogene encodes transcription factor that cooperate with c-Fos and c-Jun for transcriptional activation. Nature, 346, 191-3.
56. Logan SK, Garabedian MJ, Campbell CE and Werb Z, 1996, Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem, 271, 774-82.